Clinical Trial Update: Comparing SonoVue With Sonazoid Using CEUS-LIRADS in HCC [Phase 3]

View source ↗

Summary

Phase 3 trial comparing SonoVue and Sonazoid using CEUS-LIRADS in hepatocellular carcinoma patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Hepatocellular Carcinoma

Drugs mentioned

• Sonazoid (perflubutane)
• SonoVue (sulfur hexafluoride microbubbles)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Hepatocellular Carcinoma, Cirrhosis | Phase 3 | Status: UNKNOWN